Also trades as: DRTS (NASDAQ) · $vol 3M
DRTSW NASDAQ
Alpha Tau Medical Ltd.
1W: +52.8%
1M: +163.7%
3M: +138.1%
YTD: +627.0%
1Y: +998.0%
3Y: +348.3%
$2.39
-0.30 (-11.15%)
Weekly Expected Move ±40.6%
$0
$1
$2
$3
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$236.7M
52W Range0.3251-2.69
Volume243,859
Avg Volume26,890
Beta1.12
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOUzi Sofer
Employees125
SectorHealthcare
IndustryBiotechnology
IPO Date2022-03-08
Websitealphatau.com
Building B3
Jerusalem 9777605
IL
Jerusalem 9777605
IL
972 3 577 4115
About Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers. The company was founded in 2015 and is headquartered in Jerusalem, Israel.
Latest News
Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update
Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update
Alpha Tau to Participate in May Investor Conferences
Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial, with 100% Local Disease Control, 67% Complete Response Rate, and Favorable Safety Profile Observed - Conference Call Scheduled for 8:30am ET
Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Avruch Michael | 0 | — | 2026-03-18 | |
| Avruch Michael | 0 | — | 2026-03-18 | |
| Avruch Michael | 0 | — | 2026-03-18 | |
| Avruch Michael | 15,527 | $6.41 | 2026-03-18 | |
| KIDRON NADAV | 0 | — | 2026-03-18 |